image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Crest Nicholson

May 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRST
  • Price:
  • 268p
House builder Crest Nicholson was a Trader Portfolio 1 constituent and hit a pre-pandemic high of 521p in February ’20, but sentiment has turned negative due to the perceived risk of increased provisions for high rise cladding rectification. Nevertheless, its AGM  produced a strong trading update with demand for its homes remaining very high with the private sales rate of 0.98x per outlet per week comfortably above last year’s 0.81x. As a result, the group is now 84% forward sold for FY’22 (year to October).Although build cost inflation continues to edge up, selling price increases are offsetting this and while management reference “macro and geopolitical uncertainties that will create new challenges,” it thinks demand for properti ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X